| Literature DB >> 29173432 |
Mario Ganau1, Langston T Holly2, Junichi Mizuno3, Michael G Fehlings4.
Abstract
The diagnosis and treatment of degenerative cervical myelopathy (DCM) has been evolving over the past 5 decades as a result of collaborations between clinicians and scientists. The most recent trends in basic and clinical research include advances in imaging, clinical diagnostic tools, molecular genetics, surgical techniques, and reparative/regenerative strategies. Spine surgeons are witnessing a fast-paced evolution, which is reshaping the management strategies available for an aging population that suffers increasingly from this degenerative condition.Entities:
Keywords: Biomaterials; Biomedical engineering; Degenerative cervical myelopathy; Nanotechnology; Neuroprotective drugs; Osteobiologics; Regenerative strategies; Spinal implants
Mesh:
Substances:
Year: 2018 PMID: 29173432 DOI: 10.1016/j.nec.2017.09.006
Source DB: PubMed Journal: Neurosurg Clin N Am ISSN: 1042-3680 Impact factor: 2.509